Last reviewed · How we verify

NCT02790697: ICALIC

The ICALIC Accuracy Validation in Geneva Study

Status unknown Last updated 27 September 2019
What this trial tests

trial testing Indirect calorimetry in Critical Illness in 30 participants. Status unknown.

Timeline
10 September 2017
Primary endpoint
31 December 2018
31 December 2019

Quick facts

Lead sponsorUniversity Hospital, Geneva
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date10 September 2017
Primary completion31 December 2018
Estimated completion31 December 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Geneva

Who can join

18 and older, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at validating the accuracy of the new indirect calorimeter (Q-NRG, COSMED, Italy), developed for the ICALIC multicenter study. The validation of accuracy will only be conducted in Geneva center. The measurements made with the new calorimeter will be compared to the measurements by the mixing chamber method using a mass spectrometer (MAX300-LG, Extrel, USA) for gas composition analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Indirect calorimetry

Trials testing the same drug.

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other University Hospital, Geneva trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02790697.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing